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Abstract The transfer of xylose from UDP-xylose to the core
L-linked mannose of N-linked oligosaccharides by L1,2-xylosyl-
transferase (XylT) is a widespread feature of plant glycoproteins
which renders them immunogenic and allergenic in man. Here,
we report the isolation of the Arabidopsis thaliana XylT gene,
which contains two introns and encodes a 60.2 kDa protein with a
predicted type II transmembrane protein topology typical for
Golgi glycosyltransferases. Upon expression of A. thaliana XylT
cDNA in the baculovirus/insect cell system, a recombinant
protein was produced that exhibited XylT activity in vitro.
Furthermore, the recombinant enzyme displayed XylT activity in
vivo in the insect cells, as judged by the acquired cross-reaction of
cellular glycoproteins with antibodies against the L1,2-xylose
epitope. The cloned XylT cDNA as well as the recombinant
enzyme are essential tools to study the role of L1,2-xylose in the
immunogenicity and allergenicity of plant glycoproteins at the
molecular level.
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1. Introduction
N-Glycosylation is one of the major posttranslational mod-
i¢cations of proteins in eukaryotes. In both plant and animal
cells, a highly conserved multistep biosynthetic pathway co-
valently links carbohydrate side-chains to asparagine residues
of newly synthesised proteins. Animal and plant glycoproteins
contain both oligomannosidic and complex-type N-linked gly-
cans. However, complex plant N-glycans are generally smaller
than their animal counterparts, lack sialic acid but contain
instead L1,2-xylose and/or core K1,3-fucose residues. The anti-
genicity of complex plant N-glycans is well documented [1^5].
Since both L1,2-xylose and/or core K1,3-fucose are not found
on mammalian glycoproteins, they constitute epitopes for car-
bohydrate-reactive antibodies. Due to the ubiquitous occur-
rence of complex plant N-glycans throughout the plant king-
dom, these antibodies are probably responsible for the
frequently observed cross-reactivity of otherwise unrelated
plant glycoproteins [2,6]. It is also likely that complex plant
N-glycans constitute a major class of the so-called ‘carbohy-
drate cross-reactive determinants’ reactive with IgE antibodies
in the sera of many allergic patients [5,7^12]. While the clin-
ical role of carbohydrate cross-reactive determinants remains
controversial, they frequently obscure (at least in vitro) the
identi¢cation of the cause of allergic symptoms. The speci¢c
importance of L1,2-xylose to the allergenicity of plant glyco-
proteins has been reported [4,13].
The enzyme that catalyses the transfer of xylose to the N-
linked oligosaccharides of glycoproteins is L1,2-xylosyltrans-
ferase (XylT). Although the characterisation of this enzyme
from Acer pseudoplatanus [13] and its puri¢cation from soy-
beans [14] have been reported, the isolation of XylT cDNAs
has so far remained elusive. In the present paper however, we
report the cloning of the cDNA containing the entire coding
sequence of Arabidopsis thaliana XylT, its predicted amino
acid sequence and demonstrate its authentic enzymatic activ-
ity in vitro and in vivo.
2. Materials and methods
2.1. Plant material, reverse transcription PCR and sequencing
A. thaliana (var. Columbia) plants were cultivated in a controlled
growth chamber at 22‡C (day and night), a 16 h photoperiod and 50%
humidity.
Total RNA was isolated from A. thaliana leaves using the TRIzol
reagent (Life Technologies). The RNA was treated with DNase
(Promega, RQ1 RNase-free DNase) to remove traces of genomic
DNA. First-strand cDNA was synthesised from 2 Wg of total RNA
using AMV reverse transcriptase (Promega) and oligo(dT) primers
(Sigma). PCR ampli¢cation was carried out using Pfu polymerase
(Promega), primer XT1, 5P-ATGAGTAAACGGAATCCGAAG-3P,
and primer XT2, 5P-TTAGCAGCCAAGGCTCTTCAT-3P. After a
¢rst denaturation step at 94‡C for 2 min, 30 cycles of 1 min at
92‡C, 40 s at 53‡C and 3.5 min at 72‡C were performed. The ¢nal
extension step was carried out at 72‡C for 8 min. PCR products were
subcloned into pUC19. Plasmid DNA was puri¢ed with the aid of the
Qiagen plasmid puri¢cation kit and subjected to cycle sequencing
using the Big Dye Terminator Sequencing Ready Mix and an ABI
PRISM 310 Genetic analyser (Applied Biosystems, Perkin Elmer).
DNA and protein sequence analysis was performed using the DNAS-
TAR Lasergene-software package. Rapid ampli¢cation of cDNA ends
(RACE) was carried out with the 5P-RACE system (Life Technolo-
gies) according to the manufacturer’s instructions and Strasser et al.
[15].
2.2. Expression of XylT in insect cells
The A. thaliana XylT cDNA was subcloned into the baculovirus
transfer vector pVL1393 (PharMingen). Spodoptera frugiperda Sf-9
cells were grown in IPL-41 medium (Sigma) supplemented with 5%
heat-inactivated foetal calf serum at 27‡C. 1 Wg of recombinant bacu-
lovirus transfer vector was cotransfected with 200 ng linear Baculo-
Gold DNA (PharMingen) into 1U106 Sf-9 cells using lipofectin (Life
Technologies) according to the manufacturer’s protocol. Cells were
incubated for 6 days at 27‡C. The supernatant was used to infect
2U106 Sf-21 cells cultured as above. Cells were incubated for 4 days
at 27‡C, harvested and washed twice with phosphate-bu¡ered saline
solution. The cells were resuspended and lysed in the following bu¡er
(1 ml per 107 cells) : 100 mM MES bu¡er, pH 7.0, 1% Triton X-100,
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1 mM dithiothreitol, 1 mM PMSF, 5 Wg/ml leupeptin (Sigma), 5 Wg/ml
E-64 (Serva), and then incubated on ice for 30 min.
2.3. XylT activity assay
The assay mixtures contained, in a total volume of 20 Wl, 13 Wl
of homogenised transfected or uninfected cells (negative controls),
2 nmol dabsylated GnGn-hexapeptide (dabsyl-Val-Gly-Glu-(GlcNAc2-
Man3GlcNAc2)Asn-Arg-Thr) as acceptor substrate [16], 1 mM UDP-
xylose as donor substrate, 10 mM ATP and 20 mM MnCl2. 2-Acet-
amido-1,2-dideoxynojirimycin (a kind gift of Prof. A. Stu«tz, Techni-
sche Universita«t Graz, Austria) was included at a ¢nal concentration
of 1 mM to prevent degradation of acceptor and product by endog-
enous N-acetylhexosaminidases. The samples were incubated for 1 h
at 37‡C and analysed by matrix-assisted laser desorption ionisation
time-of-£ight (MALDI-TOF) mass spectrometry as previously de-
scribed [16]. Activity was calculated from the peak area of the xylo-
sylated product at 2393 Da in comparison with that of the acceptor
substrate at 2261 Da.
2.4. Characterisation of the XylT product
Pyridylaminated XylT product was prepared essentially as de-
scribed above but with GnGn-pyridylamine (GlcNAc2Man3Glc-
NAc2-PA) as the substrate and with an incubation time of 4 h. Prod-
uct was separated from acceptor substrate by reversed-phase high
performance liquid chromatography (HPLC) [17] and digested with
N-acetyl-L-glucosaminidase from bovine kidney (Sigma) prior to re-
puri¢cation by HPLC. This material, presumably MMX (Man3-
XylGlcNAc2), was itself subjected to limited digestion with K-manno-
sidase from jack beans (Sigma), thus removing all of the K1,3-linked
plus some of the K1,6-linked mannosyl residues, prior to incubation
with recombinant L1,2-xylosidase from Xanthomonas sp. (Prozyme,
San Leandro, CA, USA). Reference compound M0X-PA (Man-
2XylGlcNAc2-PA, which lacks the K1,3-linked mannose) was pre-
pared by chemical defucosylation of pineapple stem bromelain N-gly-
cans [17]. See reference [17] for abbreviations of glycan structures.
2.5. Detection of XylT activity in vivo in Sf-21 cells
Sf-21 cells infected with recombinant baculovirus carrying A. thali-
ana XylT cDNA were harvested and washed twice with phosphate-
bu¡ered saline solution. The cells were resuspended in 25 mM Tris^
HCl bu¡er, pH 7.2, and disrupted by sonication on ice. Proteins were
separated by 12% (w/v) SDS^PAGE, silver-stained or blotted onto
nitrocellulose membranes. The membranes were blocked with 3%
(w/v) bovine serum albumin (BSA) (Sigma). Polyclonal anti-horserad-
ish peroxidase (HRP) antibodies (Sigma), reactive with L1,2-xylose
and core K1,3-fucose, were pre-incubated for 30 min with either 50
Wg/ml BSA-MM (Man3GlcNAc2-glycopeptide attached to BSA) or
BSA-M0X conjugates [2]. BSA-M0X and BSA-M0XF3 (Man-
2XylFucGlcNAc2) were used as controls. The blots were developed
using goat anti-rabbit immunoglobulin conjugated to HRP (Amer-
sham Pharmacia Biotech), Supersignal West Pico Chemiluminescent
substrate (Pierce) and Hyper¢lm ECL (Amersham Pharmacia Bio-
tech).
3. Results and discussion
3.1. Cloning of A. thaliana XylT cDNA
An A. thaliana BAC sequence present in the DDBJ data-
base (A. thaliana chromosome 5 genomic sequence, accession
Fig. 1. cDNA and deduced protein sequence from A. thaliana XylT. The proposed membrane-spanning region is underlined.
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number: AB015479) revealed homology to two putative inter-
nal peptides (GLEYHAIN and SQVQAIHDASVIIGAH-
GAGLTHIVSAL) derived from soybean XylT [14,18]. Com-
parative analysis of these sequences using the Gene¢nder
program (Phil Green, University of Washington, http://
dot.imgen.bcm.tmc.edu) revealed an open reading frame of
1602 nucleotides (two putative introns excluded). To isolate
the cDNA clone corresponding to this genomic sequence, the
oligonucleotide primers XT1 and XT2 were designed which
include the putative start and stop codons of the gene, respec-
tively. Using these primers, we obtained a PCR fragment of
1605 bp from A. thaliana leaf cDNA. This PCR fragment
revealed upon sequence analysis 100% identity to the genomic
sequence. The cDNA sequence also con¢rmed the presence of
two introns in the genomic clone. The open reading frame
encodes a 534 amino acid protein with a calculated molecular
mass of 60.2 kDa (Fig. 1). RACE analysis at the 5P-end of the
cDNA con¢rmed the predicted start codon of the gene.
Hydrophobicity analysis of the deduced amino acid se-
quence of XylT, using SOSUI software package (http:
//azusa.proteome.bio.tuat.ac.jp/) with manual re¢nements, re-
vealed a type II transmembrane protein topology typical of all
previously cloned Golgi-located glycosyltransferases, exhibit-
ing a putative cytoplasmic domain of 10 residues at the
N-terminus followed by a transmembrane region and a
C-terminal putative catalytic domain. GenBank and SwissProt
database searches did not reveal signi¢cant sequence similar-
ities to known DNA or protein sequences except to a hybrid
aspen EST clone (accession number A162640).
3.2. Detection of in vitro activity of XylT
Recombinant baculoviruses were constructed to express the
entire coding sequence of A. thaliana XylT cDNA in S. fru-
giperda Sf-21 cells. When assayed for XylT activity with spe-
ci¢c substrates, the lysates of cells infected with the recombi-
nant viruses were found to display signi¢cant enzymatic
activity, whereas no activity was detectable in uninfected cells
(Fig. 2).
The authenticity of the reaction product obtained with
GnGn-PA as acceptor substrate was veri¢ed by reversed-
phase HPLC and exoglycosidase digestion. After sequential
removal of terminal GlcNAc- and 1,3-linked K-mannosyl res-
idues, the product of XylT action co-eluted as anticipated
with M0X-PA and was sensitive to treatment with L1,2-xylo-
sidase (data not shown). Taken together, these data provide
good evidence that the recombinant A. thaliana enzyme had
transferred xylose in L1,2-linkage to the L-mannosyl residue of
the core pentasaccharide moiety of N-linked oligosaccharides.
Fig. 2. Demonstration of XylT activity of the recombinant enzyme. Cell extracts of A. thaliana XylT expressing insect cells were incubated
with dabsylated GnGn-hexapeptide as described in Section 2. The mixtures were analysed by MALDI-TOF mass spectrometry. A: Extract of
1.3U105 uninfected Sf-21 cells. The peaks at 2261.7 and 2283.9 Da represent the [M+H] and the [M+Na] ions, respectively, of the acceptor
substrate (S) which is accompanied by an in-source fragmentation product (S*). B: Extract of approximately 1.3U105 Sf-21 cells expressing A.
thaliana XylT. The xylosylated product (P) is detected by means of peaks at 2393.4 and 2415.5 Da corresponding to the [M+H] and the
[M+Na] ions, respectively.
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3.3. Determination of in vivo activity of XylT
To date, no endogenous L1,2-XylT activity has been re-
ported in insect cells. Consequently, cellular glycoproteins
are devoid of xylosylated N-glycans (see [19] for review). In-
deed, protein extracts from uninfected Sf-21 cells did not
cross-react with a polyclonal anti-HRP antiserum which con-
tains antibodies to N-glycans containing L1,2-xylose and core
K1,3-fucose [2]. However, cross-reaction was observed upon
baculoviral expression of XylT cDNAs in these cells. The
speci¢city of the anti-glycan antibodies was assessed by West-
ern blotting of the neoglycoconjugates BSA-M0X and BSA-
M0XF3. When the antiserum was preadsorbed with the con-
trol neoglycoprotein BSA-MM, both BSA-M0X (containing
L1,2-xylose) and BSA-M0XF3 (containing both L1,2-xylose
and core K1,3-fucose) exhibited reactivity with the anti-glycan
antibodies. Preadsorption with BSA-M0X completely abol-
ished binding to this neoglycoprotein. However, BSA-
M0XF3 was detected to a signi¢cant extent even after the
latter pretreatment. In contrast, the acquired cross-reactivity
of XylT expressing Sf-21 cells with the anti-HRP antibodies
was strongly reduced after preadsorption with BSA-M0X
(compare B to C in Fig. 3). Taken together, these experiments
indicate that expression of A. thaliana XylT cDNA in insect
cells results in the L1,2-xylosylation of endogenous glycopro-
teins, suggesting proper targeting of the recombinant enzyme
to the insect Golgi apparatus and the utilisation of intracel-
lular pools of UDP-xylose.
In conclusion, the present data indicate that we have iden-
ti¢ed the gene that encodes XylT of A. thaliana. We did not
detect signi¢cant homologies to any other nucleotide or pro-
tein sequence. Since the core K1,3-fucosyltransferase from
mung beans has recently also been cloned and functionally
expressed in insect cells [16], we now have recombinant forms
of two important plant glycosyltransferases whose products
are involved in the allergenicity and immunogenicity in hu-
mans. Large quantities of puri¢ed enzyme can now be pro-
duced thus allowing the in vitro synthesis of homogeneous N-
glycans containing L1,2-xylose and/or core K1,3-fucose. Such
‘vegetabilised’ structures will aid the further elucidation of the
role of these compounds in the immunogenicity and allerge-
nicity of plant glycoproteins. Together with the recently iden-
ti¢ed genes of tobacco N-acetylglucosaminyl-transferase I
(GnT I) [15] and A. thaliana N-acetylglucosaminyltransferase
II (Strasser, R., Steinkellner, H., Bore¤n, M., Altmann, F.,
Mach, L., Glo«ssl, J. and Mucha, J., submitted for publica-
tion), there are now four glycosyltransferases from the plant
N-glycosylation pathway characterised at a molecular level.
Thus, we now have the genetic tools to speci¢cally modify
the N-glycosylation pathway with the aim to produce more
‘mammalianised’ glycoproteins in plants. Furthermore, we
can now start to study the subcellular localisation of these
glycosyltransferases as it has already been reported for GnT
I [20], in an e¡ort to characterise the architecture of the plant
Golgi apparatus.
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Fig. 3. Detection of XylT in vivo activity in insect cells. A: silver-stained gel; B and C: corresponding Western blot analyses. B: Anti-HRP
pre-incubated with BSA-M0X, C: anti-HRP pre-incubated with BSA-MM. Lane 1: uninfected Sf-21 cells (2U105), lanes 2 and 3: Sf-21 cells
(2U105) infected with recombinant baculoviruses containing XylT cDNA, lane 4: BSA-M0X (200 ng), lane 5: BSA-M0XF3 (200 ng).
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